Dr. Orsi Giricz joined the Leukemia and Lymphoma Society and the Research Grants Team in 2018. Orsi brings more than 15 years of academic research experience to LLS, in both the solid and liquid tumor space. She champions basic science and discovery research at the organization, and she is the science officer for the Discovery Grant Program. She is also spearheading research and science communications both externally and internally: from educating and informing our staff to launching LLS Research on various social media platforms. She created and still maintains the publicly available Project Finder web page showcasing the breadth of blood cancer research we fund.
Prior to joining LLS, Dr. Giricz was a Faculty Associate and Senior Scientist at the Albert Einstein College of Medicine, where her research focused on various blood cancers, as well as cutaneous malignant melanoma, and triple negative breast cancer. She was the project lead on the Fire Department of New York/Einstein/Memorial Sloan Kettering Cancer Center collaboration—screening all 9/11 first responders for early signs of hematological malignancies. She also studied mechanisms of drug/CAR-T resistance in acute lymphoblastic leukemia. Orsi has published in numerous peer reviewed journals and still actively contributes to on-going blood cancer research. Dr. Giricz received her Master of Science degree in Molecular Biology and Immunology from Eötvös Loránd University in Hungary, and her Doctorate in Biochemistry from Florida Atlantic University. She completed her post-doctoral training at the Albert Einstein College of Medicine.